Lataa...
PCSK9 inhibitor valuation: A science‐based review of the two recent models
Low‐density lipoprotein cholesterol (LDL‐C) has been extensively evaluated. Prospective cohort studies, randomized controlled trials, biology, pathophysiology, genetics, and Mendelian randomization studies, have clearly taught us that LDL‐C causes atherosclerotic cardiovascular disease. The newest c...
Tallennettuna:
| Julkaisussa: | Clin Cardiol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley Periodicals, Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5947644/ https://ncbi.nlm.nih.gov/pubmed/29512936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22924 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|